ScripsAmerica Inc

PINK:SCRCQ USA Pharmaceutical Retailers
Market Cap
$14.11K
Market Cap Rank
#44595 Global
#14111 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.05
About

ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. The company also provides pharmacy dispensing services for individual doctors, as well as billing and administrative services to independent pharmacies. In addition, it distributes pharmaceutical products to independent pharmacies and other medical providers. The company was founded in 2008 and is based in Cli… Read more

ScripsAmerica Inc (SCRCQ) - Net Assets

Latest net assets as of March 2015: $-4.75 Million USD

Based on the latest financial reports, ScripsAmerica Inc (SCRCQ) has net assets worth $-4.75 Million USD as of March 2015.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.92 Million) and total liabilities ($9.66 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-4.75 Million
% of Total Assets -96.47%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

ScripsAmerica Inc - Net Assets Trend (2010–2014)

This chart illustrates how ScripsAmerica Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for ScripsAmerica Inc (2010–2014)

The table below shows the annual net assets of ScripsAmerica Inc from 2010 to 2014.

Year Net Assets Change
2014-12-31 $-3.52 Million -36.85%
2013-12-31 $-2.57 Million -117.55%
2012-12-31 $-1.18 Million -12959.98%
2011-12-31 $-9.06K -103.42%
2010-12-31 $264.89K --

Equity Component Analysis

This analysis shows how different components contribute to ScripsAmerica Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 106810.5% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2014)

Component Amount Percentage
Common Stock $136.94K %
Other Comprehensive Income $-1.31 Million %
Other Components $16.35 Million %
Total Equity $-3.25 Million 100.00%

ScripsAmerica Inc Competitors by Market Cap

The table below lists competitors of ScripsAmerica Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ScripsAmerica Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2013 to 2014, total equity changed from -2,574,393 to -3,245,931, a change of -671,538.
  • Net loss of 4,731,046 reduced equity.
  • Share repurchases of 1,715,195 reduced equity.
  • Other comprehensive income decreased equity by 1,314,180.
  • Other factors increased equity by 7,088,883.

Equity Change Factors (2013 to 2014)

Factor Impact Contribution
Net Income $-4.73 Million -145.75%
Share Repurchases $1.72 Million -52.84%
Other Comprehensive Income $-1.31 Million -40.49%
Other Changes $7.09 Million +218.39%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares ScripsAmerica Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2010-12-31 $0.00 $0.00 x
2011-12-31 $0.00 $0.00 x
2012-12-31 $-0.02 $0.00 x
2013-12-31 $-0.04 $0.00 x
2014-12-31 $-0.03 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently ScripsAmerica Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -15.33%
  • • Asset Turnover: 5.47x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is below the historical average (9.59%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2010 47.97% 3.94% 5.11x 2.38x $100.58K
2011 0.00% -5.71% 2.95x 0.00x $-339.05K
2012 0.00% -47.55% 1.66x 0.00x $-1.74 Million
2013 0.00% -2012.82% 0.31x 0.00x $-10.94 Million
2014 0.00% -15.33% 5.47x 0.00x $-4.41 Million

Industry Comparison

This section compares ScripsAmerica Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.

Industry Context

  • Industry: Pharmaceutical Retailers
  • Average net assets among peers: $239,198,060
  • Average return on equity (ROE) among peers: -6.39%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
ScripsAmerica Inc (SCRCQ) $-4.75 Million 47.97% N/A $12.60K
Alibaba Health Information Technology Limited (ALBBY) $1.12 Billion -18.54% 0.50x $12.50 Billion
Allstar Health Brands Inc (ALST) $-9.92 Million 0.00% 0.00x $3.83
Bimi International Medical Inc (BIMI) $-409.66K 0.00% 0.00x $296.83
Blum Holdings Inc (BLMH) $-4.74 Million 0.00% 0.00x $8.97 Million
China Jo-Jo Drugstores Inc (CJJD) $26.66 Million -21.17% 1.52x $5.94 Million
Clicks Group Ltd (CLCGY) $1.13 Billion 41.98% 2.72x $4.80 Billion
China BCT Pharmacy Group Inc (CNBI) $134.27 Million 15.68% 0.82x $0.96
Dalrada Financial Corp (DFCO) $4.40 Million -81.82% 0.55x $1.57 Million
Health Advance Inc (HADV) $-105.34K 0.00% 0.00x $25.40K
Healthwarehouse.Com (HEWA) $-3.10 Million 0.00% 0.00x $720.96